159 related articles for article (PubMed ID: 14520121)
1. Thrombocytopenia during valproic acid treatment in young patients with new-onset bipolar disorder.
De Berardis D; Campanella D; Matera V; Gambi F; La Rovere R; Sepede G; Grimaldi MR; Pacilli AM; Salerno RM; Ferro FM
J Clin Psychopharmacol; 2003 Oct; 23(5):451-8. PubMed ID: 14520121
[TBL] [Abstract][Full Text] [Related]
2. Valproate-induced thrombocytopenia: a prospective monotherapy study.
Nasreddine W; Beydoun A
Epilepsia; 2008 Mar; 49(3):438-45. PubMed ID: 18031547
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of quetiapine monotherapy in rapid-cycling bipolar disorder in comparison with sodium valproate.
Langosch JM; Drieling T; Biedermann NC; Born C; Sasse J; Bauer H; Walden J; Bauer M; Grunze H
J Clin Psychopharmacol; 2008 Oct; 28(5):555-60. PubMed ID: 18794653
[TBL] [Abstract][Full Text] [Related]
4. Does valproic acid warrant therapeutic drug monitoring in bipolar affective disorder?
Haymond J; Ensom MH
Ther Drug Monit; 2010 Feb; 32(1):19-29. PubMed ID: 19901867
[TBL] [Abstract][Full Text] [Related]
5. Platelet count and function in children receiving sodium valproate.
Verrotti A; Greco R; Matera V; Altobelli E; Morgese G; Chiarelli F
Pediatr Neurol; 1999 Sep; 21(3):611-4. PubMed ID: 10513686
[TBL] [Abstract][Full Text] [Related]
6. Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder.
Friedman SD; Dager SR; Parow A; Hirashima F; Demopulos C; Stoll AL; Lyoo IK; Dunner DL; Renshaw PF
Biol Psychiatry; 2004 Sep; 56(5):340-8. PubMed ID: 15336516
[TBL] [Abstract][Full Text] [Related]
7. Increase in platelet count in older, poor-risk patients with acute myeloid leukemia or myelodysplastic syndrome treated with valproic acid and all-trans retinoic acid.
Pilatrino C; Cilloni D; Messa E; Morotti A; Giugliano E; Pautasso M; Familiari U; Cappia S; Pelicci PG; Lo Coco F; Saglio G; Guerrasio A
Cancer; 2005 Jul; 104(1):101-9. PubMed ID: 15895376
[TBL] [Abstract][Full Text] [Related]
8. Cost analysis of divalproex sodium extended-release compared to valproic acid in the treatment of bipolar disorder.
Schumock GT; Walton SM; Gupta SR; Cramer JA
Curr Med Res Opin; 2007 Aug; 23(8):1997-2004. PubMed ID: 17637202
[TBL] [Abstract][Full Text] [Related]
9. Effect of valproate on hemostatic function in patients with traumatic brain injury.
Anderson GD; Temkin NR; Chandler WL; Winn HR
Epilepsy Res; 2003 Dec; 57(2-3):111-9. PubMed ID: 15013052
[TBL] [Abstract][Full Text] [Related]
10. The effect of valproic acid on blood loss in patients with cerebral palsy.
Chambers HG; Weinstein CH; Mubarak SJ; Wenger DR; Silva PD
J Pediatr Orthop; 1999; 19(6):792-5. PubMed ID: 10573351
[TBL] [Abstract][Full Text] [Related]
11. The influence of old age and enzyme inducing comedication on the pharmacokinetics of valproic acid at steady-state: A case-matched evaluation based on therapeutic drug monitoring data.
Fattore C; Messina S; Battino D; Croci D; Mamoli D; Perucca E
Epilepsy Res; 2006 Aug; 70(2-3):153-60. PubMed ID: 16730950
[TBL] [Abstract][Full Text] [Related]
12. The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status.
Hamed SA; Abdella MM
Epilepsy Res; 2009 Sep; 86(1):32-41. PubMed ID: 19446440
[TBL] [Abstract][Full Text] [Related]
13. Valproate-mediated disturbances of hemostasis: relationship to dose and plasma concentration.
Gidal B; Spencer N; Maly M; Pitterle M; Williams E; Collins M; Jones J
Neurology; 1994 Aug; 44(8):1418-22. PubMed ID: 8058141
[TBL] [Abstract][Full Text] [Related]
14. Possible interaction between lopinavir/ritonavir and valproic Acid exacerbates bipolar disorder.
Sheehan NL; Brouillette MJ; Delisle MS; Allan J
Ann Pharmacother; 2006 Jan; 40(1):147-50. PubMed ID: 16368918
[TBL] [Abstract][Full Text] [Related]
15. Decreased thyroid function in Korean women with bipolar disorder receiving valproic acid.
Park YM; Kang SG; Lee BH; Lee HJ
Gen Hosp Psychiatry; 2011; 33(2):200.e13-5. PubMed ID: 21596216
[TBL] [Abstract][Full Text] [Related]
16. Valproate-associated hyperammonemic encephalopathy.
Wadzinski J; Franks R; Roane D; Bayard M
J Am Board Fam Med; 2007; 20(5):499-502. PubMed ID: 17823470
[TBL] [Abstract][Full Text] [Related]
17. Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls.
Elmslie JL; Porter RJ; Joyce PR; Hunt PJ; Shand BI; Scott RS
Aust N Z J Psychiatry; 2009 Jan; 43(1):53-60. PubMed ID: 19085528
[TBL] [Abstract][Full Text] [Related]
18. Effect of platelet count on secretion capacity: formulization and use of the formulae for evaluation of platelet secretion in thrombocytopenic patients.
Buyukasik Y; Goker H; Buyukasik NS; Sayinalp N; Haznedaroglu IC; Ozcebe OI
Blood Coagul Fibrinolysis; 2008 Oct; 19(7):633-7. PubMed ID: 18832902
[TBL] [Abstract][Full Text] [Related]
19. Extracorporeal management of valproic acid toxicity: a case report and review of the literature.
Al Aly Z; Yalamanchili P; Gonzalez E
Semin Dial; 2005; 18(1):62-6. PubMed ID: 15663767
[TBL] [Abstract][Full Text] [Related]
20. [Phase II clinical trial on China manufactured recombinant human interleukin-11 derivative in the prevention and treatment of chemotherapy-induced thrombocytopenia].
Wang XY; Feng FY; Song ST; Wang HQ; Zhang MH; Liu J; Liu XY; Xu LG; Zhang Y
Zhonghua Zhong Liu Za Zhi; 2005 Jun; 27(6):373-6. PubMed ID: 16117903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
